These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11888585)

  • 21. The influence of age, sex, vitamin B(12), folate levels and methylenetetrahydrofolate reductase C677T genetic mutations on plasma homocysteine in the Chinese population.
    Ho CH
    Haematologica; 2000 Oct; 85(10):1051-4. PubMed ID: 11025596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
    Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China.
    Li Z; Sun L; Zhang H; Liao Y; Wang D; Zhao B; Zhu Z; Zhao J; Ma A; Han Y; Wang Y; Shi Y; Ye J; Hui R;
    Stroke; 2003 Sep; 34(9):2085-90. PubMed ID: 12907815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
    Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap.
    Smulders YM; Smith DE; Kok RM; Teerlink T; Swinkels DW; Stehouwer CD; Jakobs C
    Br J Haematol; 2006 Mar; 132(5):623-9. PubMed ID: 16445837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine].
    Quéré I; Chassé JF; Dupuy E; Bellet E; Molho-Sabatier P; Tobelem G; Janbon C
    Rev Med Interne; 1998 Jan; 19(1):29-33. PubMed ID: 9775112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis.
    Kluijtmans LA; Boers GH; Verbruggen B; Trijbels FJ; Novakova IR; Blom HJ
    Blood; 1998 Mar; 91(6):2015-8. PubMed ID: 9490685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism of methylenetetrahydrofolate reductase and venous thromboembolism: a case-control study.
    González Ordóñez AJ; Fernández Alvarez CR; Rodríguez JM; García EC; Alvarez MV
    Haematologica; 1999 Feb; 84(2):190-1. PubMed ID: 10091425
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
    Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
    Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians.
    Naushad SM; Jain Jamal MN; Prasad CK; Rama Devi AR
    Clin Chem Lab Med; 2008; 46(1):73-9. PubMed ID: 18034637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.
    Hsu TS; Hsu LA; Chang CJ; Sun CF; Ko YL; Kuo CT; Chiang CW; Lee YS
    Thromb Res; 2001 Jun; 102(5):387-95. PubMed ID: 11395124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk.
    Kluijtmans LA; Whitehead AS
    Eur Heart J; 2001 Feb; 22(4):294-9. PubMed ID: 11161947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperhomocysteinemia and deep-vein thrombosis].
    Qiu L; Yan SK; Song YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):706-9. PubMed ID: 14714317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5).
    Gris JC; Quéré I; Monpeyroux F; Mercier E; Ripart-Neveu S; Tailland ML; Hoffet M; Berlan J; Daurès JP; Marès P
    Thromb Haemost; 1999 Jun; 81(6):891-9. PubMed ID: 10404763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should plasma homocysteine be used as a biomarker of venous thromboembolism? A case-control study.
    Ducros V; Barro C; Yver J; Pernod G; Polack B; Carpentier P; Desruet MD; Bosson JL
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):517-22. PubMed ID: 18818229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.
    Simsek E; Yesilyurt A; Pinarli F; Eyerci N; Ulus AT
    Gene; 2014 Feb; 536(1):171-6. PubMed ID: 24334115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.